German court upholds cancer treatment award

A Taiwanese pharmaceuticals company has failed to overturn an award in a billion-euro ICC dispute over a blood cancer drug based on allegations it was not allowed to fully defend itself.


Get unlimited access to all Global Arbitration Review content